What are the urodynamic findings in Parkinson disease and multiple system atrophy?

Urodynamic Findings in Parkinson's Disease vs Multiple System Atrophy

Urodynamic studies can reliably distinguish MSA from PD, with MSA patients showing predominantly impaired bladder emptying (high postvoid residual >150mL, weak detrusor contractility, detrusor-sphincter dyssynergia), while PD patients primarily exhibit storage dysfunction (detrusor overactivity with preserved contractility and lower postvoid residuals).

Key Distinguishing Features

Multiple System Atrophy (MSA)

Voiding Phase Dysfunction Predominates:

• Postvoid residual (PVR) >150mL - strongest discriminator with 74.8% sensitivity and 75.9% specificity 1
• Markedly reduced maximal flow rate (4.0 ± 5.8 mL/s) 1
• Severely impaired detrusor contractility (bladder contractility index 24.9 ± 33.8) 1
• Decreased bladder compliance (44.9% of patients) 1
• Detrusor-sphincter dyssynergia - present in 90.6% of MSA patients 2
• Hypoactive detrusor with low urethral pressure - characteristic pattern 3

Clinical Context:

• Urinary symptoms appear early (<2 years from disease onset) 4
• Detrusor underactivity with dysuria develops in 58% within 4 years, 76% thereafter 4
• All MSA patients show hyperreflexia with vesicosphincteric synergy 2
• Sphincter EMG shows neurogenic changes in 75% of MSA patients (vs 0% in PD) 2

Parkinson's Disease (PD)

Storage Phase Dysfunction Predominates:

• Detrusor overactivity (DO) with associated urine leakage - most prominent finding 1
• Preserved bladder contractility (bladder contractility index 65.7 ± 51.1) 1
• Lower postvoid residual (134.0 ± 188.1 mL) 1
• Higher maximal flow rate (9.1 ± 8.3 mL/s) 1
• Normal bladder compliance (89.3% of patients) 1

Clinical Context:

• Urinary symptoms appear late (>5 years from disease onset) 4
• 36.6% have completely normal urodynamic findings 2
• When abnormal: 26.7% show hyperreflexia with synergy, 26.7% have delayed pelvic floor relaxation 2
• Normal sphincter EMG in all PD patients 2

Diagnostic Algorithm Using Urodynamics

Step 1: Timing of Urinary Symptoms

• <2 years from motor onset → suspect MSA

• 5 years from motor onset → more consistent with PD

Step 2: Primary Symptom Pattern

• Dysuria with chronic retention → MSA
• Urgency/frequency without retention → PD

Step 3: Key Urodynamic Parameters (in order of diagnostic utility)

1. PVR from pressure-flow study (best discriminator)

   • 150mL strongly suggests MSA (OR 8.723) 5

   • <150mL more consistent with PD

2. Detrusor pressure at maximal uroflow

   • Low pressure with low flow → MSA (detrusor underactivity)
   • Normal/high pressure with normal flow → PD

3. Bladder contractility index

   • <25 → MSA

   • 65 → PD

4. Detrusor overactivity with leakage

   • Present → PD
   • Absent with dyssynergia → MSA

Step 4: Sphincter EMG (if available)

• Neurogenic changes → MSA (24/32 patients) 2
• Normal → PD (30/30 patients) 2

Clinical Pearls and Pitfalls

Critical Distinctions:

• MSA shows detrusor-urethral dyssynergia best characterized by multiple sensor pressure transducers at different urethral levels 4
• PD may show delayed pelvic floor relaxation but maintains vesicosphincteric synergy 2
• In MSA, urodynamic abnormalities appear before advanced disease stages 2

Common Pitfalls:

• Single PVR measurement insufficient - the AUA/SUFU guidelines emphasize that PVR has marked intra-individual variability 6
• DO absence on single study doesn't exclude it in PD 6
• Early MSA may be misdiagnosed as PD if urodynamics not performed 1

Guideline Context: The AUA/SUFU guidelines recommend CMG as an option for neurologic diseases like PD, though its utility for preventing renal complications is less clear than in spinal cord injury 6. However, CMG accurately diagnoses detrusor dysfunction in these subgroups 6. For MSA, given the high risk of upper tract complications from elevated storage pressures and retention, urodynamic evaluation is clinically essential despite not being specifically mandated in the general neurologic disease recommendations.

When to Perform Urodynamics:

• At initial evaluation when differential diagnosis between MSA and PD is uncertain 1
• When urinary symptoms appear unusually early in presumed PD 4
• Before invasive treatments for LUTS in parkinsonian patients 6
• When monitoring for upper tract complications in MSA 7